Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-13 5:56 pm Purchase | 2025-12-31 | 13G | CYTOSORBENTS CORP CTSO | AVENIR CORP | 261,505 8.300% | 106,808 (+69.04%) | Filing History |
| 2025-05-28 6:47 pm Purchase | 2024-06-26 | 13G | CYTOSORBENTS CORP CTSO | Avenue Venture Opportunities Fund, L.P. | 187,764 5.700% | 187,764 (New Position) | Filing History |
| 2025-04-30 10:59 am Sale | 2025-03-31 | 13G | CYTOSORBENTS CORP CTSO | VANGUARD GROUP INC | 97,478 3.110% | -97,477 (-50.00%) | Filing History |
| 2025-04-17 2:22 pm Purchase | 2025-03-31 | 13G | CYTOSORBENTS CORP CTSO | Skylands Capital LLC | 150,135 4.800% | 11,054 (+7.95%) | Filing History |
| 2025-02-14 10:22 am Purchase | 2024-12-31 | 13G | CYTOSORBENTS CORP CTSO | AVENIR CORP | 154,697 5.700% | 2,127 (+1.39%) | Filing History |
| 2025-01-31 6:49 pm Purchase | 2024-12-31 | 13G | CYTOSORBENTS CORP CTSO | VANGUARD GROUP INC | 194,955 7.130% | 97,114 (+99.26%) | Filing History |
| 2025-01-17 4:05 pm Purchase | 2025-01-13 | 13G | CYTOSORBENTS CORP CTSO | Thomas A. Satterfield, Jr. | 199,943 6.560% | 199,943 (New Position) | Filing History |
| 2025-01-07 1:26 pm Sale | 2024-12-31 | 13G | CYTOSORBENTS CORP CTSO | Skylands Capital LLC | 139,081 5.100% | -23,630 (-14.52%) | Filing History |
| 2024-11-14 4:48 pm Sale | 2024-09-30 | 13G | CYTOSORBENTS CORP CTSO | Granahan Investment Management LLC | 104,744 3.850% | -76,163 (-42.10%) | Filing History |
| 2024-02-14 4:42 pm Purchase | 2023-12-31 | 13G | CYTOSORBENTS CORP CTSO | AVENIR CORP | 152,570 6.870% | 30,216 (+24.70%) | Filing History |
| 2024-02-14 09:00 am Purchase | 2023-12-31 | 13G | CYTOSORBENTS CORP CTSO | Granahan Investment Management LLC | 180,907 6.930% | 180,907 (New Position) | Filing History |
| 2024-01-08 3:00 pm Purchase | 2023-12-31 | 13G | CYTOSORBENTS CORP CTSO | Skylands Capital LLC | 162,711 7.300% | 35,606 (+28.01%) | Filing History |
| 2023-02-14 1:08 pm Purchase | 2022-12-31 | 13G | CYTOSORBENTS CORP CTSO | AVENIR CORP | 122,354 5.610% | 12,965 (+11.85%) | Filing History |
| 2023-02-09 11:16 am Sale | 2022-12-30 | 13G | CYTOSORBENTS CORP CTSO | VANGUARD GROUP INC | 97,841 4.480% | -12,617 (-11.42%) | Filing History |
| 2023-02-07 2:28 pm Purchase | 2022-12-31 | 13G | CYTOSORBENTS CORP CTSO | Skylands Capital LLC | 127,105 5.800% | 127,105 (New Position) | Filing History |
| 2022-08-11 08:39 am Purchase | 2022-07-26 | 13G | CYTOSORBENTS CORP CTSO | AVENIR CORP | 109,389 5.020% | 1,547 (+1.43%) | Filing History |
| 2022-07-08 4:57 pm Sale | 2022-06-30 | 13G | CYTOSORBENTS CORP CTSO | BlackRock, Inc. BLK | 37,248 1.700% | -94,313 (-71.69%) | Filing History |
| 2022-06-27 5:34 pm Sale | 2022-05-26 | 13G | CYTOSORBENTS CORP CTSO | AVENIR CORP | 107,842 4.950% | -1,015 (-0.93%) | Filing History |
| 2022-04-22 5:34 pm Purchase | 2022-03-22 | 13G | CYTOSORBENTS CORP CTSO | AVENIR CORP | 108,857 5.000% | 4,453 (+4.27%) | Filing History |
| 2022-02-09 3:43 pm Sale | 2021-12-31 | 13G | CYTOSORBENTS CORP CTSO | VANGUARD GROUP INC | 110,458 5.080% | -622 (-0.56%) | Filing History |